Oncology Target definition

Oncology Target shall have the meaning set forth in Section 3.4.2.
Sample 1Sample 2
Oncology Target means a protein and any structural or other variant, subunit, fragment or derivative thereof that is identified by or on behalf of NextCure with the NextCure Collaboration Technology, NextCure Materials and/or FIND-IOTM Technology under the Research Collaboration.
Sample 1Sample 2
Oncology Target means (a) [*]or (b) [*], or (c) [*].
Sample 1

Examples of Oncology Target in a sentence

  • The Research Program will be carried out in accordance with a written research and development plan that sets forth all research and development activities of the Parties with respect to each Collaboration Target through the Development Transition Date with respect to such Collaboration Target and, prior to designation of the Oncology Target in accordance with Section 3.3, all research activities with respect to Target Pool microRNAs for the purpose of identifying the Oncology Target (the “R&D Plan”).

  • Pages, Neuropilins, as Relevant Oncology Target: Their Role in the Tumoral Microenvironment.

  • Current experimental and Translational Evidence.- 7 Genetic polymor- phisms in the µ-opioid receptor gene and breast can- cer survival.- 8 Anaesthetic and pain management technique in long term cancer outcome - benefits of regional anaesthesia and analgesia in the[...] Fields of interestCancer Research; Pharmacy; Pharmacology / Toxi- cology; Pain Medicine; Oncology Target groupsResearch Type of publicationContributed volumeMore on www.springer.com/978-94-007-5677-9Hardcover2013.

  • During the Research Term, AstraZeneca shall have the right to provide Regulus with a written notice of the Target Pool microRNA it wishes to designate as the Oncology Target (each such note, a “Request Notice” and each such microRNA, a “Proposed Oncology Target”).

  • Class preservation‌In this section we investigate the kernel of the retraction r : IsomHo(pro-ss)↓ket (Xet, Yet) → Isomk(X, Y )constructed in the proof of Theorem 4.7. Because the retraction is functorial, we may pass by composingγ with (r(γ)−1)et to the situation where X = Y and r(γ) = id X .

  • At any point during the Term, subject to this Section 7.5, each Party will have the right to publish summaries of results from any pre-clinical studies and/or human clinical trials generated by AstraZeneca and/or Regulus with respect to the Target Pool microRNA, Collaboration Targets (including the Oncology Target), Lead Compounds or Products in strict accordance with this Section 7.5 and any publication plan agreed by the Parties and attached to the R & D Plan.

  • The final part of the 3 positioning accuracy curves also shows a progressive increase in the geometric errors generated by imprecise assembly of the beam (αz - beam longitudinal axis deviation from IR’s Y axis) as well as imprecise assembly of the Z axis slide (αy- slide longitudinal axis deviation from IR’s Z axis, by rotation around the IR’s Y axis).

  • The center operator shall provide UBC NJCTF, at no cost, the following equipment and support services as part of the center operator’s contract.

  • As of the Amendment Effective Date, there are [***] Research Targets: the AstraZeneca Exclusive Target, [***] AstraZeneca CV Targets and the AstraZeneca Oncology Target.

  • Fields of interestCancer Research; Human Genetics; Molecular Medi- cine; Gastroenterology; Oncology Target groupsResearch Type of publicationContributed volumeMore on www.springer.com/978-94-007-6596-2Hardcover2013.


More Definitions of Oncology Target

Oncology Target means (i) any of the three Reserved Targets that are selected under Section 3.3.6 to be the subject of an Oncology Collaboration Program, (ii) any Substitute Target, or (iii) any oncology target added to this Agreement under Section 2.2.4.
Sample 1

Related to Oncology Target

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • KPI Target means the acceptable performance level for a KPI as set out in each KPI;

  • Development Team means the entities and professionals assembled to develop and manage the Project, typically including the Applicant, Owner, Developer(s), Co-Developer(s) and general partner or any other related entities in which the Developer or Co-Developer has an identity of interest or a Controlling Interest.

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Soft Target means a target that will suffer minimum damage and cause minimum damage to the subject vehicle in the event of a collision.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Clinical Director means an individual who meets the minimum requirements set forth in Title 9, CCR, and has at least two (2) years of full-time professional experience working in a mental health setting.

  • Novartis shall have the meaning set forth in the Preamble.

  • BMS means the Company, all related companies, affiliates, subsidiaries, parents, successors, assigns and all organizations acquired by the foregoing.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Research Term has the meaning set forth in Section 3.2.

  • Physical therapy licensing board or "licensing board" means the agency of a state that is responsible for the licensing and regulation of physical therapists and physical therapist assistants.

  • Merck has the meaning set forth in the preamble.

  • Gene Therapy means the introduction of a nucleic acid sequence encoding a protein intended for or otherwise conferring therapeutic benefit into a person for therapeutic purposes (i) by in vivo introduction for incorporation into cells of such person, or (ii) by ex vivo introduction into cells for transfer into a person.

  • Moving beam radiation therapy means radiation therapy with any planned displacement of radiation field or patient relative to each other, or with any planned change of absorbed dose distribution. It includes arc, skip, conformal, intensity modulation and rotational therapy.

  • Research Program Term has the meaning set forth in Section 2.2.

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • ISIS means the department’s individualized services information system.

  • Phase I Clinical Study means, as to a particular Licensed Product, an initial clinical study in humans with the purpose of assessing the Licensed Product’s safety, tolerability, toxicity, pharmacokinetics or other pharmacological properties.

  • Development Milestone Event shall have the meaning set forth in Section 9.2(a).

  • site development plan means a dimensioned plan drawn to scale that indicates details of the proposed land development, including the site layout, positioning of buildings and structures, property access, building designs and landscaping;

  • Development Term means the period commencing on the Closing Date and ending on the earlier of (a) the Option Closing Date or (b) the date the Option terminates or expires other than by exercise.

  • POC (Proof of Concept) means testing the Software for evaluation purposes.

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.

  • Development Milestone Payment shall have the meaning set forth in Section 9.2(a).

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.